Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Emerging Role of IL-4-Induced Gene 1 as a Prognostic Biomarker Affecting the Local T-Cell Response in Human Cutaneous Melanoma.
Ramspott JP, Bekkat F, Bod L, Favier M, Terris B, Salomon A, Djerroudi L, Zaenker KS, Richard Y, Molinier-Frenkel V, Castellano F, Avril MF, Prévost-Blondel A. Ramspott JP, et al. J Invest Dermatol. 2018 Dec;138(12):2625-2634. doi: 10.1016/j.jid.2018.06.178. Epub 2018 Jul 23. J Invest Dermatol. 2018. PMID: 30048651 Free article.
Progressive upregulation of PD-1 in primary and metastatic melanomas associated with blunted TCR signaling in infiltrating T lymphocytes.
Chapon M, Randriamampita C, Maubec E, Badoual C, Fouquet S, Wang SF, Marinho E, Farhi D, Garcette M, Jacobelli S, Rouquette A, Carlotti A, Girod A, Prévost-Blondel A, Trautmann A, Avril MF, Bercovici N. Chapon M, et al. J Invest Dermatol. 2011 Jun;131(6):1300-7. doi: 10.1038/jid.2011.30. Epub 2011 Feb 24. J Invest Dermatol. 2011. PMID: 21346771 Free article.
Early T cell signalling is reversibly altered in PD-1+ T lymphocytes infiltrating human tumors.
Wang SF, Fouquet S, Chapon M, Salmon H, Regnier F, Labroquère K, Badoual C, Damotte D, Validire P, Maubec E, Delongchamps NB, Cazes A, Gibault L, Garcette M, Dieu-Nosjean MC, Zerbib M, Avril MF, Prévost-Blondel A, Randriamampita C, Trautmann A, Bercovici N. Wang SF, et al. PLoS One. 2011 Mar 7;6(3):e17621. doi: 10.1371/journal.pone.0017621. PLoS One. 2011. PMID: 21408177 Free PMC article.
IL4I1: an inhibitor of the CD8⁺ antitumor T-cell response in vivo.
Lasoudris F, Cousin C, Prevost-Blondel A, Martin-Garcia N, Abd-Alsamad I, Ortonne N, Farcet JP, Castellano F, Molinier-Frenkel V. Lasoudris F, et al. Eur J Immunol. 2011 Jun;41(6):1629-38. doi: 10.1002/eji.201041119. Epub 2011 May 13. Eur J Immunol. 2011. PMID: 21469114 Free PMC article.
Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4+ T cells.
Pommier A, Audemard A, Durand A, Lengagne R, Delpoux A, Martin B, Douguet L, Le Campion A, Kato M, Avril MF, Auffray C, Lucas B, Prévost-Blondel A. Pommier A, et al. Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):13085-90. doi: 10.1073/pnas.1300314110. Epub 2013 Jul 22. Proc Natl Acad Sci U S A. 2013. PMID: 23878221 Free PMC article.
49 results